ReviewFrontiers in medicine2026

The FDA's adoption of Bayesian methodology: transforming clinical trial justification from biosimilars to broader drug development.

Sarfaraz K NiaziPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.